A Double-Blind, Placebo-Controlled, Randomized withdrawal Trial to Evaluate the Efficacy and Safety of TAK-861 for the Treatment of Narcolepsy with Cataplexy (Narcolepsy Type 1)
Clinical Trial Grant
Administered By
Neurology, Epilepsy and Sleep
Awarded By
Takeda Development Center Americas, Inc
Start Date
January 22, 2026
End Date
December 31, 2028
Administered By
Neurology, Epilepsy and Sleep
Awarded By
Takeda Development Center Americas, Inc
Start Date
January 22, 2026
End Date
December 31, 2028